Hepatitis C Antibody
Anti-HCV· also: HCV Ab, HCV Antibody, HepC Ab
Clinical Overview
Anti-HCV (Hepatitis C Antibody) detects antibodies produced against Hepatitis C virus (HCV). It is the standard first-line screening test for Hepatitis C infection. A positive (reactive) result requires confirmation with HCV RNA PCR because Anti-HCV remains positive for life — even after the infection has been successfully treated and cleared.
Why This Test Matters
Hepatitis C affects approximately 58 million people globally and is a leading cause of liver cirrhosis and hepatocellular carcinoma. Unlike Hepatitis B, HCV has no vaccine, but it is now curable with direct-acting antivirals (DAAs) with >95% cure rates. The diagnostic algorithm: positive Anti-HCV → confirm with HCV RNA PCR (detects active viremia). Positive Anti-HCV + detectable HCV RNA = current active infection (needs treatment). Positive Anti-HCV + undetectable HCV RNA = past resolved infection (or successfully treated). HCV RNA becomes detectable 1–2 weeks post-exposure, before Anti-HCV (which appears at 6–12 weeks). Anti-HCV never develops in a small proportion of immunocompromised patients despite active infection — use HCV RNA for screening in these patients.
Reference RangesWHO/IFCC standards
| Reference Range | Unit | Notes |
|---|---|---|
| Negative / Non-reactive | qualitative | Non-reactive = no HCV antibodies |
Also reported in: S/CO ratio.
What Causes Abnormal Results?
High Anti-HCV Causes
- Active chronic Hepatitis C infection (most common)
- Resolved past HCV infection (antibody persists lifelong after clearance)
- Successfully treated HCV (Anti-HCV remains positive even after cure — confirms by undetectable HCV RNA)
- IV drug use with shared needles (most common transmission route in developed countries)
- Blood transfusion before 1992 (before HCV screening of blood supply)
- Hemodialysis (historical nosocomial transmission)
- Perinatal transmission from HCV-positive mother
Low Anti-HCV Causes
- Immunosuppressed patients may fail to develop Anti-HCV despite active HCV infection — use HCV RNA PCR directly in high-risk immunocompromised patients
- Early acute HCV infection (within 6–12 weeks of exposure) may be Anti-HCV negative — window period
Signs & Symptoms to Watch For
How to Prepare for This Test
No fasting required. Anti-HCV screening can be done at any time. A reactive Anti-HCV result should automatically trigger reflex HCV RNA PCR testing to determine if infection is current.
Factors That Can Affect Results
- Immunosuppression (HIV, organ transplant recipients, chemotherapy) — can delay or prevent Anti-HCV seroconversion
- High-dose biotin supplementation interferes with some immunoassays
- Anti-HCV remains positive for life after resolved infection — always confirm with HCV RNA to determine active vs. past infection
Related Topics
Frequently Asked Questions
My Anti-HCV came back positive — does this mean I have Hepatitis C?
A positive Anti-HCV means you were exposed to Hepatitis C at some point. It does NOT automatically mean you currently have the infection. You need an HCV RNA PCR test to determine if the virus is still present. If HCV RNA is detectable — you have active Hepatitis C and should be treated. If HCV RNA is undetectable — you either cleared the infection naturally (about 25–30% of people clear acute HCV spontaneously) or you were previously treated and cured. Anti-HCV stays positive for life regardless of cure.
Is Hepatitis C curable?
Yes — modern direct-acting antiviral (DAA) medications cure Hepatitis C in over 95% of patients with an 8–12 week course of oral tablets. Sustained virologic response (SVR) — defined as undetectable HCV RNA 12 weeks after completing treatment — is equivalent to a cure. Anti-HCV antibodies remain positive after cure (the immune system keeps the memory), but HCV RNA becomes undetectable. Treatment also dramatically reduces risk of cirrhosis and liver cancer. There is no vaccine for Hepatitis C, but anyone who clears or is cured can be re-infected if re-exposed.